4.8 Article

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2

期刊

NATURE GENETICS
卷 43, 期 6, 页码 539-U67

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.838

关键词

-

资金

  1. US National Heart, Lung and Blood Institute [R01HL068927, R01HL068890, R01HL095396]
  2. US National Institute of Diabetes and Digestive and Kidney Diseases [R01DK066368, K23DK083551, P30DK027651]
  3. US National Institute of Mental Health [SOLAR-MH059490]
  4. US National Human Genome Research Institute [HG-0004314]
  5. US Cystic Fibrosis Foundation [CUTTIN00A0, CUTTIN06P0, COLLAC07A0, RDP-R025-CR07, KNOWLE00A0, RDP-R026-CR07, DRUMM0A00, GENOMEQUEBEC07DDS0]
  6. Flight Attendant Medical Research Institute [FAMRI2006]
  7. Lawson Wilkins Pediatric Endocrine Society
  8. Canadian Cystic Fibrosis Foundation
  9. Genome Canada through the Ontario Genomics Institute [2004-OGI-3-05]
  10. Ontario Research Fund
  11. Lloyd Carr-Harris Foundation
  12. Canadian Institutes of Health Research
  13. Ontario Women's Health Council
  14. US Cystic Fibrosis Foundation (CFF)

向作者/读者索取更多资源

A combined genome-wide association and linkage study was used to identify loci causing variation in cystic fibrosis lung disease severity. We identified a significant association (P = 3.34 x 10(-8)) near EHF and APIP (chr11p13) in p. Phe508del homozygotes (n = 1,978). The association replicated in p. Phe508del homozygotes (P = 0.006) from a separate family based study (n = 557), with P = 1.49 x 10(-9) for the three-study joint meta-analysis. Linkage analysis of 486 sibling pairs from the family based study identified a significant quantitative trait locus on chromosome 20q13.2 (log(10) odds = 5.03). Our findings provide insight into the causes of variation in lung disease severity in cystic fibrosis and suggest new therapeutic targets for this life-limiting disorder.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据